Fig. 2From: Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001–2018)(Source: South African National Department of Health)Number of local and imported cases reported in Mpumalanga Province by year with arrows indicating the first-line anti-malarial treatments deployed over the reporting period (2000–2018)Back to article page